Atlas Trials

ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer

Clinical trial NCT06810141 · AVAILABLE

Trial details

NCT number
NCT06810141
Sponsor
ImmunityBio, Inc.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
NMIBC

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.